Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound annual growth rate (CAGR) of 11.07% from 2024 (237.64 billion USD estimated at the end of 2023) to 2033 (679.03 billion USD expected by the end of 2033).
Indigenous women living “off reserve” face many disparities in health care access
Indigenous females living “off reserve” face many disparities in health care access, use and unmet needs, found new research in CMAJ (Canadian Medical Association Journal)
August 28, 2023